Skip to main content
. 2021 Oct 12;11:20219. doi: 10.1038/s41598-021-99507-2

Figure 1.

Figure 1

Overview of the used data. (A) Schematic of the NCT02313272 protocol indicating the imaging and treatment time point for this triple combination therapy trial. (B) Out of the 32 trial participants only those 16 with monitored tumor progression were included in this analysis.